House-passed CBR - $75 million in New Money re: Diabetes

[sr71]

The US House of Representatives just passed a 25 page Continuing Budget Resolution (CBR) to avoid a gov't shutdown at midnight tomorrow. (Note:  It would still require Senate concurrence and presidential approval to become law).

docs.house.gov/billsthisweek/20171218/BILLS-115HR1370-RCP115-52.pdf

Pages 13-14 of this bill include specific funding authorization for two diabetes programs:

    A.  One is in the amount of $37.5 million for "Special diabetes programs for type I diabetes" (42 U.S.C. 254c–2(b)(2)):  www.law.cornell.edu/uscode/text/42/254c-2

         This program appears to have been funded from FY's 1998-2015, with no appropriations for FY's 2016-2017.  Specifically, these funds "provide for research into the prevention and cure of Type I diabetes".

    B.  The second program (also in the amount of $37.5 million) is to fund "Special Diabetes Program For Indians" ((42 U.S.C. 254c–3(c)(2)):  www.law.cornell.edu/uscode/text/42/254c-3

         Similarly, this program appears to have been funded from FY's 1998-2015, with no appropriations for FY's 2016-2017. Specifically, these funds "make grants for providing services for the prevention and  

         treatment of diabetes".

This news seems relevant on a couple of levels:

    1.    In light of the present partisan difficulties in passing any legislation, why did these programs all of a sudden become priorities now after having not been funded for two years?

    2.    These two programs' stated collective missions are to fund diabetes "prevention", "cure", and "treatment", all of which have been apparent failures as evidenced by continued escalation in diabetes rates. 

           (Native American populations have particularly high diabetes rates.)

So the questions could become:

    a.    What will be different (if anything) with the approaches that these programs utilize this time around in an apparent attempt to achieve better results?

    b.    Could any such approaches involve the use of Human Insulin?

    c.    From what source could such programs obtain the only FDA-approved Human Insulin?

Hmmmm . . .

[sayhey24]

It sounds like VDex should be reaching out to every Indian tribe and setting up a clinic.

[bioexec25]

Hopefully the Veterans Administration relationship with Mannkind will be strengthened. Also with the military for that matter with TS.

[falconquest]

Dec 21, 2017 18:31:56 GMT -5 sr71 said:

The US House of Representatives just passed a 25 page Continuing Budget Resolution (CBR) to avoid a gov't shutdown at midnight tomorrow. (Note:  It would still require Senate concurrence and presidential approval to become law).

docs.house.gov/billsthisweek/20171218/BILLS-115HR1370-RCP115-52.pdf

Pages 13-14 of this bill include specific funding authorization for two diabetes programs:

    A.  One is in the amount of $37.5 million for "Special diabetes programs for type I diabetes" (42 U.S.C. 254c–2(b)(2)):  www.law.cornell.edu/uscode/text/42/254c-2

         This program appears to have been funded from FY's 1998-2015, with no appropriations for FY's 2016-2017.  Specifically, these funds "provide for research into the prevention and cure of Type I diabetes".

    B.  The second program (also in the amount of $37.5 million) is to fund "Special Diabetes Program For Indians" ((42 U.S.C. 254c–3(c)(2)):  www.law.cornell.edu/uscode/text/42/254c-3

         Similarly, this program appears to have been funded from FY's 1998-2015, with no appropriations for FY's 2016-2017. Specifically, these funds "make grants for providing services for the prevention and  

         treatment of diabetes".

This news seems relevant on a couple of levels:

    1.    In light of the present partisan difficulties in passing any legislation, why did these programs all of a sudden become priorities now after having not been funded for two years?

    2.    These two programs' stated collective missions are to fund diabetes "prevention", "cure", and "treatment", all of which have been apparent failures as evidenced by continued escalation in diabetes rates. 

           (Native American populations have particularly high diabetes rates.)

So the questions could become:

    a.    What will be different (if anything) with the approaches that these programs utilize this time around in an apparent attempt to achieve better results?

    b.    Could any such approaches involve the use of Human Insulin?

    c.    From what source could such programs obtain the only FDA-approved Human Insulin?

Hmmmm . . .

This is known as the Christmas Tree bill where legislators tack on amendments that help their State. That way they can go home for the holidays and tell their constituents that they are working hard for them. It is nice to see a couple of diabetes related amendments but I don't think it will result in much.